Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate Alzheimer’s disease by up to 8.3 years in low-amyloid group who started ...
FreeBSD 15 brings noticeable improvements thanks to strong industry support: New features include package management, cloud, ...
Chem Pharmacies is seeking a Merchandiser for its Vaal Mall store in Vanderbijlpark, Gauteng. This permanent position ...
Dr. Maureen Allem explores how to navigate menopause, and the strategies and treatments available to them at this ...